Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease

Exclusion Criteria

• •Pregnant and lactating women.
• •Patients who have any history of esophageal bleeding, hepatic encephalopathy, ascites.
• •Diabetes, thyroid dysfunction, fatty liver, liver cancer patients.
• •Toxic hepatitis, alcoholic hepatitis.
• •Total bilirubin value more than 3.0 mg/dl.
• •Albumin value less than 3.0 g/dl.
• •Patients who participating in other study about drug.